AI Analysis AI Analysis of SNOA
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Strong day for Sonoma Pharmaceuticals Inc stock price on Monday rising 5.23% to $3.62
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Oct 31, 2025 Loss -8.12%

The Sonoma Pharmaceuticals Inc stock price gained 5.23% on the last trading day (Monday, 17th Nov 2025), rising from $3.44 to $3.62. During the last trading day the stock fluctuated 5.80% from a day low at $3.45 to a day high of $3.65. The price has fallen in 6 of the last 10 days and is down by -4.23% for this period. Volume fell on the last day by -1 thousand shares and in total, 7 thousand shares were bought and sold for approximately $26.88 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.32% during the next 3 months and, with a 90% probability hold a price between $2.55 and $2.98 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SNOA Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, November 14, 2025, and so far it has risen 5.23%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sonoma Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.62 and $3.88. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sonoma Pharmaceuticals Inc stock

Sonoma Pharmaceuticals Inc finds support from accumulated volume at $3.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.200 between high and low, or 5.80%. For the last week the stock has had daily average volatility of 5.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SNOA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Sonoma Pharmaceuticals Inc to open at $3.57, and during the day (based on 14 day Average True Range), to move between $3.51 and $3.73, which gives a possible trading interval of +/-$0.223 (+/-6.35%) up or down from last closing price. If Sonoma Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 6.35% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.54 (2.21%) than the resistance at $4.07 (12.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Sonoma Pharmaceuticals Inc stock A Buy?

Sonoma Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.338 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $3.57 ( 1.29%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

SNOA Performance

Trading levels for SNOA

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.77 4.24%
R2 3.70 2.13%
R1 3.65 0.82%
Price 3.62
S1 3.50 -3.40%
S2 3.45 -4.70%
S3 3.37 -6.81%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.40 21.55%
R2 4.25 17.40%
R1 4.07 12.43%
Price 3.62
S1 3.54 -2.21%
S2 3.44 -4.97%
S3 0 -

FAQ

What is the symbol for Sonoma Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Sonoma Pharmaceuticals Inc is SNOA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sonoma Pharmaceuticals Inc Stock?
Sonoma Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Sonoma Pharmaceuticals Inc Stock?
Sonoma Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sonoma Pharmaceuticals Inc Stock.

What's the current price of Sonoma Pharmaceuticals Inc Stock?
As of the end of day on the Nov 17, 2025, the price of an Sonoma Pharmaceuticals Inc (SNOA) share was $3.62.

What is the 52-week high and low for Sonoma Pharmaceuticals Inc Stock?
The 52-week high for Sonoma Pharmaceuticals Inc Stock is $6.92 and the 52-week low is $1.75.

What is the market capitalization of Sonoma Pharmaceuticals Inc Stock?
As of the Nov 17, 2025, the market capitalization of Sonoma Pharmaceuticals Inc is 6.158M.

When is the next earnings date for Sonoma Pharmaceuticals Inc?
The upcoming earnings date for Sonoma Pharmaceuticals Inc is Feb 04, 2026.
Click to get the best stock tips daily for free!
ABOUT SONOMA PHARMACEUTICALS INC
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE